Source: FDA

Date: 01/19/06

Headline: FDA Approves Updated Labeling with Boxed Warning and Medication Guide for Two Eczema Drugs, Elidel and Protopic

The FDA is requiring two popular eczema creams to carry "black box" warnings - the strongest type of warning - of possible cancer risk. The label warns that patients only use these drugs after other treatments have failed. Animal tests have shown that these drugs may cause cancer.